AD-9308
/ Foresee Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
November 03, 2025
Deciphering endothelial aldehyde dehydrogenase 2, oxidative stress, and interleukin-6 interactions in pulmonary hypertension: Implications for precision medicine.
(PubMed, Biochem Pharmacol)
- "Moreover, these effects were mitigated by AD-9308, a prodrug of AD-5591...This study highlights the role of endothelial ALDH2 dysfunction and 4-HNE accumulation in pulmonary arterial (PA) remodeling via the p38/NF-κB/IL-6 pathway. Our findings suggest that ALDH2 enhancers may represent a promising precision medicine approach for PH management, particularly in patients with ALDH2 deficiency."
Journal • Cardiovascular • Hypertension • Pulmonary Arterial Hypertension • Pulmonary Disease • Respiratory Diseases • ALDH2 • FGF2 • IL6
November 09, 2023
4-Hydroxynonenal impairs miRNA maturation in heart failure via Dicer post-translational modification.
(PubMed, Eur Heart J)
- "4-HNE inhibition of Dicer directly impairs miRNA biogenesis in heart failure. Strikingly, decreasing cardiac 4-HNE levels through pharmacological ALDH2 activation is sufficient to re-establish Dicer activity and miRNA biogenesis; thereby representing potential treatment for patients with heart failure."
Journal • Cardiovascular • Congestive Heart Failure • Heart Failure • Metabolic Disorders • ALDH2
1 to 2
Of
2
Go to page
1